Rigel Pharmaceuticals, Inc. ( RIGL) - Key Metrics

RIGL Revenue per Share metrics
Date Revenue per Share Net Income per Share Operating Cash Flow Free Cash Flow per Share
2026Q2 $4.24 $0.93 $1.80 $1.80
2026Q1 $3.19 $0.47 $0.15 $0.15
2025Q4 $3.88 $14.90 $1.22 $1.22
2025Q3 $3.85 $1.55 $1.33 $1.33
2025Q2 $5.69 $3.33 $1.71 $1.71

RIGL Payout ratio and Price per Earnings ratio
Date Payout ratio PE ratio
2026Q2 0% 10.52
2026Q1 0% 14.38
2025Q4 0% 0.73
2025Q3 0% 4.57
2025Q2 0% 1.41

RIGL Free Cash Flow Yield and Dividend Yield
DateFree Cash Flow YieldDividend Yield
2026Q2 4.60% 0%
2026Q1 0.55% 0%
2025Q4 2.85% 0%
2025Q3 4.70% 0%
2025Q2 9.12% 0%

RIGL

Price: $43.62

52 week price:
24.95
52.24

Earnings Per Share: 16.89 USD

P/E Ratio: 2.38

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 2.8 million

Ebitda: -17.7 million

Market Capitalization: 750.4 million

Links: